CDC, hepatitis B
Digest more
The result, if approved by the CDC's acting director, will be a rollback of a universal recommendation to start hepatitis B immunization at birth, a standard practice in the U.S. for more than 30 year
The change represents a continued shift in the agency’s vaccine policy, reflecting increasingly skeptical views.
Common anti-vaccine talking points were on display as the CDC’s immunization advisers repealed a hepatitis B birth vaccine recommendation and scrutinized the childhood schedule.
Experts warn the decision could confuse doctors, burden families, and revive preventable infections as the committee reopens the entire childhood vaccine schedule.